Literature DB >> 25853088

Utility of magnetic resonance spectroscopic imaging for human epilepsy.

Jullie W Pan1, Ruben I Kuzniecky1.   

Abstract

This review discusses the potential utility of broad based use of magnetic resonance (MR) spectroscopic imaging for human epilepsy and seizure localization. The clinical challenges are well known to the epilepsy community, intrinsic in the variability of location, volumetric size and network extent of epileptogenic tissue in individual patients. The technical challenges are also evident, with high performance requirements in multiple steps, including magnet homogeneity, detector performance, sequence design, speed of acquisition in addition to large territory spectral processing. We consider how MR spectroscopy and spectroscopic imaging has been informative for epilepsy thus far, with specific attention to what is measured, the interpretation of such measurements and technical performance challenges. Examples are shown from medial temporal lobe and neocortical epilepsies are considered from 4T, 7T and most recently 3T.

Entities:  

Keywords:  N-acetyl aspartate (NAA); Seizure localization; glial-neuronal unit; shimming; spectroscopic imaging; spectroscopy

Year:  2015        PMID: 25853088      PMCID: PMC4379323          DOI: 10.3978/j.issn.2223-4292.2015.01.03

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  48 in total

1.  Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures.

Authors:  O A Petroff; F Hyder; D L Rothman; R H Mattson
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

Review 2.  Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore.

Authors:  George B Richerson; Yuanming Wu
Journal:  J Neurophysiol       Date:  2003-09       Impact factor: 2.714

3.  Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus.

Authors:  P Saransaari; S S Oja
Journal:  Int J Dev Neurosci       Date:  1997-04       Impact factor: 2.457

4.  Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport.

Authors:  T B Patel; J B Clark
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

5.  Application of volumetric MR spectroscopic imaging for localization of neocortical epilepsy.

Authors:  Andrew A Maudsley; Claudia Domenig; R Eugene Ramsay; Brian C Bowen
Journal:  Epilepsy Res       Date:  2009-11-17       Impact factor: 3.045

6.  High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease.

Authors:  C Eggers; R Hilker; L Burghaus; B Schumacher; W D Heiss
Journal:  J Neurol Sci       Date:  2008-10-02       Impact factor: 3.181

7.  Analysis of metabolic control: new insights using scaled creatine kinase model.

Authors:  R J Connett
Journal:  Am J Physiol       Date:  1988-06

8.  Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy.

Authors:  R Kuzniecky; J W Hugg; H Hetherington; E Butterworth; E Bilir; E Faught; F Gilliam
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

9.  Metabolic networks in epilepsy by MR spectroscopic imaging.

Authors:  J W Pan; D D Spencer; R Kuzniecky; R B Duckrow; H Hetherington; S S Spencer
Journal:  Acta Neurol Scand       Date:  2012-05-11       Impact factor: 3.209

10.  Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain.

Authors:  Jullie W Pan; Kan Takahashi
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

View more
  8 in total

1.  Altered metabolomic-genomic signature: A potential noninvasive biomarker of epilepsy.

Authors:  Helen C Wu; Fabien Dachet; Farhad Ghoddoussi; Shruti Bagla; Darren Fuerst; Jeffrey A Stanley; Matthew P Galloway; Jeffrey A Loeb
Journal:  Epilepsia       Date:  2017-07-17       Impact factor: 5.864

Review 2.  UltraHigh Field MR Imaging in Epilepsy.

Authors:  Gaurav Verma; Bradley N Delman; Priti Balchandani
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-02       Impact factor: 2.266

3.  Neuroimaging outcomes for writing epilepsy with generalized tonic clonic seizure: a case description and literature analysis.

Authors:  Baodong Li; Meimei Jin; Jing Bai; Guobin Lan; Xiaowei Qiu; Jia Song; Zhenfeng Sun; Yong Liu; Zengyue Zhu
Journal:  Quant Imaging Med Surg       Date:  2022-03

4.  Brain metabolic differences between temporal lobe epileptic seizures and organic non-epileptic seizures in postictal phase: a retrospective study with magnetic resonance spectroscopy.

Authors:  Dongbao Liu; Yonggui Yang; Dicheng Chen; Zi Wang; Di Guo; Lijun Bao; Jiyang Dong; Xin Wang; Xiaobo Qu
Journal:  Quant Imaging Med Surg       Date:  2021-08

5.  Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures.

Authors:  Myriam Abdennadher; Sara Inati; Ariane Soldatos; Gina Norato; Eva H Baker; Audrey Thurm; Luca Bartolini; Ruturaj Masvekar; William Theodore; Bibiana Bielekova; Forbes D Porter; An N Dang Do
Journal:  J Inherit Metab Dis       Date:  2021-02-15       Impact factor: 4.750

Review 6.  Role of cerebral glutamate in post-stroke epileptogenesis.

Authors:  John-Paul Nicolo; Terence J O'Brien; Patrick Kwan
Journal:  Neuroimage Clin       Date:  2019-11-05       Impact factor: 4.881

7.  Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations.

Authors:  Andrew A Maudsley; Ovidiu C Andronesi; Peter B Barker; Alberto Bizzi; Wolfgang Bogner; Anke Henning; Sarah J Nelson; Stefan Posse; Dikoma C Shungu; Brian J Soher
Journal:  NMR Biomed       Date:  2020-04-29       Impact factor: 4.044

8.  Event-Associated Oxygen Consumption Rate Increases ca. Five-Fold When Interictal Activity Transforms into Seizure-Like Events In Vitro.

Authors:  Karl Schoknecht; Nikolaus Berndt; Jörg Rösner; Uwe Heinemann; Jens P Dreier; Richard Kovács; Alon Friedman; Agustin Liotta
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.